Bỏ qua để đến Nội dung
· Tái tạo sinh học da
SKU 11212

Viscoderm 2.0

Còn hàng
Dung tích
3 x 1 mL
Nhà sản xuất
IBSA
Xuất xứ
Ý
Giá bán sỉ và lịch sử giá chỉ dành cho tài khoản đã xác minh
allpara cung cấp sản phẩm cho người hành nghề có giấy phép. Đăng nhập hoặc đăng ký tài khoản B2B để xem giá theo thời gian thực, các mức giá theo số lượng và lịch sử giá.

Viscoderm 2.0 is a sterile injectable medical device by IBSA, indicated for bringing the dermis back to its normal physiological condition in cases of severe xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified healthcare professionals. The product contains 20 mg/ml of highly purified sodium hyaluronate obtained through fermentation.

Lợi ích chính của Viscoderm 2.0

  • Sterile, single-use injectable medical device, CE 0477
  • Highly purified sodium hyaluronate obtained by fermentation, not subjected to chemical modification processes
  • Molecular weight of about 1 million Dalton, very close to endogenous hyaluronic acid, making the product totally biocompatible
  • Rehydrates the tissues and favours tissue remodelling
  • Indicated for severe xerodermia associated with dermatitis and/or psoriasis
  • Sold on medical prescription only, for administration by qualified personnel
Thông tin chính
Thương hiệu Viscoderm
Nhà sản xuất IBSA
Xuất xứ Italy
Chứng nhận CE-marked medical device for intradermal use, CE 0477
Thành phần Per 1 ml syringe: sodium hyaluronate 20.000 mg; sodium chloride 8.500 mg; sodium phosphate 0.205 mg; water for injection q.s. 1.0 ml
Dung tích / Kích thước 1 ml per pre-filled syringe, 3 ml per pack
Đóng gói 3 pre-filled syringes x 1 ml, with 6 needles 30G x 12 mm
Kích thước kim 30G x 12 mm, 6 needles supplied per pack
Loại sử dụng Sold on medical prescription only. Administered by intradermal injection by qualified personnel only. Sterile, pyrogen-free, pre-filled single-use syringes.
Độ sâu tiêm Intradermal, at medium-deep level, using a linear or picotage technique
Liệu trình / Thời gian Initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Shelf life 36 months.

Chỉ định và sử dụng chuyên môn

Chỉ định chính

  • Severe xerodermia associated with dermatitis and/or psoriasis
  • Restoration of the normal physiological condition of the dermis
  • Rehydration of skin tissue where cell turnover of the stratum corneum is increased

Sử dụng chuyên môn

Viscoderm 2.0 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

Vùng điều trị

  • Intradermal administration, at medium-deep level
  • The treating practitioner determines the area treated

Đối tượng bệnh nhân

Viscoderm 2.0 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 2.0% concentration is indicated to counteract severe xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

Cơ chế hoạt động của Viscoderm 2.0 ​

Viscoderm 2.0 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 2.0% concentration is the highest of the three in the range and is the one indicated for severe xerodermia.

Vì sao nên đặt hàng tại Allpara

Allpara cung cấp sản phẩm VISCODERM chính hãng, đã được xác minh, từ các nhà cung cấp được tuyển chọn, với khả năng truy xuất lô đầy đủ và hỗ trợ chuyên môn. Chúng tôi phục vụ các phòng khám và chuyên gia thẩm mỹ với sản phẩm đạt chứng nhận CE, giao hàng nhanh khắp EU từ kho tại EU và giá chuyên nghiệp cạnh tranh. Ưu tiên của chúng tôi là sự an toàn, hài lòng và kết quả của bệnh nhân của bạn, cùng dịch vụ hậu mãi tận tâm để bạn hoàn toàn yên tâm.

Câu hỏi thường gặp

How does Viscoderm 2.0 differ from Viscoderm 0.8 and 1.6?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

What is Viscoderm 2.0 indicated for?

It is indicated for adults of both sexes, for restoration of the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, with the 2.0% concentration indicated for the severe degree.

What is the treatment schedule?

An initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions.

Who should not be treated with Viscoderm 2.0?

It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

Thêm sản phẩm từ IBSA

Xem nhà sản xuất

Lựa chọn thay thế cho phòng khám

Tất cả sản phẩm

Viscoderm 2.0

Còn hàng
Đạt dấu CE Đạt dấu CE Viscoderm 2.0
Giá chỉ dành cho tài khoản đã xác minh
Đăng nhập hoặc đăng ký tài khoản B2B để xem giá của bạn.
Đăng ký tài khoản B2B

Viscoderm 2.0 is a sterile injectable medical device by IBSA, indicated for bringing the dermis back to its normal physiological condition in cases of severe xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified healthcare professionals. The product contains 20 mg/ml of highly purified sodium hyaluronate obtained through fermentation.

Lợi ích chính của Viscoderm 2.0

  • Sterile, single-use injectable medical device, CE 0477
  • Highly purified sodium hyaluronate obtained by fermentation, not subjected to chemical modification processes
  • Molecular weight of about 1 million Dalton, very close to endogenous hyaluronic acid, making the product totally biocompatible
  • Rehydrates the tissues and favours tissue remodelling
  • Indicated for severe xerodermia associated with dermatitis and/or psoriasis
  • Sold on medical prescription only, for administration by qualified personnel
Thông tin chính
Thương hiệu Viscoderm
Nhà sản xuất IBSA
Xuất xứ Italy
Chứng nhận CE-marked medical device for intradermal use, CE 0477
Thành phần Per 1 ml syringe: sodium hyaluronate 20.000 mg; sodium chloride 8.500 mg; sodium phosphate 0.205 mg; water for injection q.s. 1.0 ml
Dung tích / Kích thước 1 ml per pre-filled syringe, 3 ml per pack
Đóng gói 3 pre-filled syringes x 1 ml, with 6 needles 30G x 12 mm
Kích thước kim 30G x 12 mm, 6 needles supplied per pack
Loại sử dụng Sold on medical prescription only. Administered by intradermal injection by qualified personnel only. Sterile, pyrogen-free, pre-filled single-use syringes.
Độ sâu tiêm Intradermal, at medium-deep level, using a linear or picotage technique
Liệu trình / Thời gian Initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Shelf life 36 months.

Chỉ định và sử dụng chuyên môn

Chỉ định chính

  • Severe xerodermia associated with dermatitis and/or psoriasis
  • Restoration of the normal physiological condition of the dermis
  • Rehydration of skin tissue where cell turnover of the stratum corneum is increased

Sử dụng chuyên môn

Viscoderm 2.0 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

Vùng điều trị

  • Intradermal administration, at medium-deep level
  • The treating practitioner determines the area treated

Đối tượng bệnh nhân

Viscoderm 2.0 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 2.0% concentration is indicated to counteract severe xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

Cơ chế hoạt động của Viscoderm 2.0 ​

Viscoderm 2.0 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 2.0% concentration is the highest of the three in the range and is the one indicated for severe xerodermia.

Vì sao nên đặt hàng tại Allpara

Allpara cung cấp sản phẩm VISCODERM chính hãng, đã được xác minh, với khả năng truy xuất lô đầy đủ, hàng đạt chứng nhận CE, giao hàng nhanh khắp EU và hỗ trợ hậu mãi chuyên nghiệp.

Câu hỏi thường gặp

How does Viscoderm 2.0 differ from Viscoderm 0.8 and 1.6?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

What is Viscoderm 2.0 indicated for?

It is indicated for adults of both sexes, for restoration of the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, with the 2.0% concentration indicated for the severe degree.

What is the treatment schedule?

An initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions.

Who should not be treated with Viscoderm 2.0?

It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

Thêm sản phẩm từ IBSA

Xem nhà sản xuất →
* Sản phẩm dùng cho chuyên môn. Bao bì có thể khác nhau tùy theo lô hoặc thị trường. Vui lòng tham khảo hướng dẫn sử dụng kèm theo để biết đầy đủ cách dùng và chống chỉ định.